Aerie Pharmaceuticals
AERI
#6477
Rank
โ‚น67.70 B
Marketcap
โ‚น1,370
Share price
0.00%
Change (1 day)
94.91%
Change (1 year)

Operating Margin for Aerie Pharmaceuticals (AERI)

Operating Margin as of December 2025 (TTM): -10.86%

According to Aerie Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -10.86%. At the end of 2021 the company had an Operating Margin of -38.23%.

Operating Margin history for Aerie Pharmaceuticals from 2019 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-38.23%-82.13%
2020-213.93%-25.12%
2019-285.70%-70.29%
2018-961.77%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Insmed
INSM
-250.21% 2,203.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-96.77% 791.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06%-386.00%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.